INCR

InterCure Ltd.

$3.60

-0.83%

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.

Source: Yahoo Finance
Q-Score41/ 100
Market Cap$46.7M
P/E—
Dividend Yield0.00%
52-Week Range—
Next Earnings—
Analysts—
Beta0.68
AI summary

Price & performance

1M-39.5%
3M-30.8%
YTD-36.0%
1Y-52.0%
52-week range—
Beta0.68
Full chart and returns against a benchmark

Q-Score

41/ 100

Quality against peers; 50 is the peer median.

Growth31
Risk52
Performance42
Valuation56
Profitability41
Leverage34
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2024

Revenue$65.4M-33.4%
Net income-$19.9M
Net margin-30.5%-12.6 pts
Historical fundamentals

Revenue exposure

Regions, segments, customers and suppliers

Valuation

INCRIndustryP/E—35.25P/S0.712.74EV/EBITDA—16.35P/B0.432.46PEG—0.87
Dividend yield0.00%
Every valuation metric